BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21725240)

  • 1. Amyotrophic lateral sclerosis: an update.
    de Carvalho M; Swash M
    Curr Opin Neurol; 2011 Oct; 24(5):497-503. PubMed ID: 21725240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis.
    Ludolph AC; Brettschneider J; Weishaupt JH
    Curr Opin Neurol; 2012 Oct; 25(5):530-5. PubMed ID: 22918486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis.
    Van Damme P; Robberecht W
    Curr Opin Neurol; 2013 Oct; 26(5):466-72. PubMed ID: 23945281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis.
    Broustal O; Camuzat A; Guillot-Noël L; Guy N; Millecamps S; Deffond D; Lacomblez L; Golfier V; Hannequin D; Salachas F; Camu W; Didic M; Dubois B; Meininger V; Le Ber I; Brice A;
    J Alzheimers Dis; 2010; 22(3):765-9. PubMed ID: 21158017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
    Mackenzie IR; Neumann M
    Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VCP mutations in familial and sporadic amyotrophic lateral sclerosis.
    Koppers M; van Blitterswijk MM; Vlam L; Rowicka PA; van Vught PW; Groen EJ; Spliet WG; Engelen-Lee J; Schelhaas HJ; de Visser M; van der Kooi AJ; van der Pol WL; Pasterkamp RJ; Veldink JH; van den Berg LH
    Neurobiol Aging; 2012 Apr; 33(4):837.e7-13. PubMed ID: 22078486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUS pathology in basophilic inclusion body disease.
    Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
    Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropathological similarities and differences between frontotemporal lobar degeneration with ubiquitin inclusions and amyotrophic lateral sclerosis with dementia].
    Tan CF; Toyoshima Y; Kakita A; Takahashi H
    Brain Nerve; 2009 Nov; 61(11):1319-27. PubMed ID: 19938689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Gijselinck I; Engelborghs S; Maes G; Cuijt I; Peeters K; Mattheijssens M; Joris G; Cras P; Martin JJ; De Deyn PP; Kumar-Singh S; Van Broeckhoven C; Cruts M
    Arch Neurol; 2010 May; 67(5):606-16. PubMed ID: 20457961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUS-related proteinopathies: lessons from animal models.
    Lanson NA; Pandey UB
    Brain Res; 2012 Jun; 1462():44-60. PubMed ID: 22342159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
    Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
    Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New diagnostic criteria of ALS (Awaji criteria)].
    Nodera H; Izumi Y; Kaji R
    Brain Nerve; 2007 Oct; 59(10):1023-9. PubMed ID: 17969342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in motor neuron disease.
    Van Damme P; Robberecht W
    Curr Opin Neurol; 2009 Oct; 22(5):486-92. PubMed ID: 19593125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosis.
    Gladman M; Cudkowicz M; Zinman L
    Curr Opin Neurol; 2012 Dec; 25(6):735-42. PubMed ID: 23160423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical considerations in the management of amyotrophic lateral sclerosis.
    Eisen A; Krieger C
    Prog Neurobiol; 2013 Nov; 110():45-53. PubMed ID: 23735671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapy options for amyotrophic lateral sclerosis.
    Gordon P; Corcia P; Meininger V
    Expert Opin Pharmacother; 2013 Oct; 14(14):1907-17. PubMed ID: 23855817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on amyotrophic lateral sclerosis genetics.
    Brenner D; Weishaupt JH
    Curr Opin Neurol; 2019 Oct; 32(5):735-739. PubMed ID: 31335339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New transgenic ALS/FTD models on the rat-walk: An Editorial Highlight for 'Increased Ubqln2 expression causes neuron death in transgenic rats'.
    Stegmüller J; Synofzik M
    J Neurochem; 2016 Oct; 139(2):159-161. PubMed ID: 27723099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.